Presenter Dr. Eric Tang, Chief, Medical & Scientific Affairs Section | Mpox Lead STD Control Branch, California Department of Public Health
Learning Objectives
Summarize current STI trends in Santa Barbara County
Describe the stages of syphilis and the recommended treatment and follow-up for people with syphilis
Describe how to diagnose, manage and treat DGI
2024 STI Clinical Update: San Francisco Department of Public Health (SFDPH)
Thursday, March 14, 2024
Hybrid event. Please note: CME not available for viewing the recording.
Presented by:
Dr. Oliver Bacon Medical Director, San Francisco City Clinic San Francisco Department of Public Health
Dr. Franco Chevalier Deputy Medical Director, San Francisco City Clinic San Francisco Department of Public Health
Dr. Stephanie Cohen Director, HIV/STI Prevention, Disease Control Branch, San Francisco Department of Public Health
Dr. Kelly Johnson Medical Director, California Prevention Training Center Public Health Medical Officer, STD Control Branch, California Department of Public Health
Emcee: Dr. Ina Park Principal Investigator, California Prevention Training Center
Description
More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in the U.S. in 2022, and San Francisco has higher chlamydia, gonorrhea, syphilis, and HIV rates compared to the rest of the state and nation. This half-day, hybrid event will provide important updates in the field of sexual health to help providers strengthen the delivery of STI prevention and care. Hear from local experts on STI epidemiology in San Francisco, updates on Doxy-PEP implementation, recognizing dermatologic manifestations of STIs, and a lively case panel.
Learning Objectives
Summarize current STI trends in San Francisco
Be familiar with updates to STI treatment guidelines and innovations in STI prevention and diagnostics
Understand how to implement Doxy-PEP for STI prevention
Recognize common dermatologic manifestations of STIs
STI Clinical Update Webinar – Introduction to Syphilis and Congenital Syphilis: A Phoenix IHS and CAPTC Event
January 11, 2024
8:30AM-12:00PM (MST)
Presented by CAPTC Clinical Faculty
Recording available 2 weeks after the webinar. Please note: CME not available for viewing the webinar recording.
Presenters:
Sharon Adler, MD, MPH, Clinical Faculty, California Prevention Training Center
Wyatt Hanft, MD, MPH, AAHIVS, STI Fellow, California Prevention Training Center
Tamara Ooms, RN, MSN, FNP, Program Manager, California Prevention Training Center
Ina Park, MD, MS, Principal Investigator, California Prevention Training Center
Rosalyn Plotzker, MD, MPH, Clinical Faculty, California Prevention Training Center
Moderator: Kelly Johnson, MD, MPH, Medical Director, California Prevention Training Center
Learning Objectives:
Describe the varied clinical manifestations of syphilis in adults & congenital syphilis (CS) in infants
Recognize that there are two different screening algorithms used to diagnose syphilis in adults
Define adequate treatment for syphilis, including during pregnancy
List at least 3 strategies to prevent syphilis in adults and infants
STI Clinical Update Humboldt County-Addressing the Rise of Syphilis: A Review of Clinical Management of Syphilis and Congenital Syphilis for Health Care Providers
Presented by Drs. Kathleen Jacobson and Wyatt Hanft
Dermatologic manifestations of STIs – Urethritis/Vaginitis (including syndromic management)
Sexual assault and STIs
Presented by:
Kelly Johnson, MD,MPH, Medical Director, California Prevention Training Center
Tamara Ooms, RN, MSN, FNP, Program Manager, California Prevention Training Center
Rosalyn Plotzker, MD, MPH, Clinical Faculty, California Prevention Training Center
Alan Katz, MD, MPH, Staff Physician, Hawai’i State Department of Health
Moderator: Breena Gaskov, BS, Outreach Epidemiological Specialist, Hawai’i State Department of Health
Learning Objectives
Explain prenatal syphilis screening and treatment recommendations
Describe the clinical and public health approaches to GC/CT prevention
Summarize data from recent studies exploring the use of doxy PEP to prevent bacterial STIs
Compare potential strategies for doxy-PEP implementation in clinical settings
Recognize dermatologic signs of sexually transmitted infections (STIs)
Delineate treatment approaches for syndromes suggestive of STIs
How to Prescribe Expedited Partner Therapy (EPT) for Sexually Transmitted Infections
How to Prescribe Expedited Partner Therapy (EPT) for Sexually Transmitted Infections
Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with certain sexually transmitted infections (STIs) – including chlamydia (CT), gonorrhea (GC), and trichomoniasis – without the health care provider first examining the partner(s). EPT usually involves patient delivered partner therapy (PDPT), in which the patient delivers the medication or a prescription to their partner(s). While evaluating the partner and providing other needed health services would be ideal, this is often not feasible. EPT can be provided confidentially; it is effective, safe, acceptable to patients and partners, and helps to ensure timely partner treatment.
This resource contains information on how to prescribe EPT in California, including sample prescriptions, information on billing/reimbursement, and patient-facing materials.
In-person laboratory course onsite at the UC San Francisco campus
Intended for practicing clinicians with prior wet mount experience and microscopy skills
Capacity limited to 8 persons
The course begins with a fifteen minute didactic presentation on applicable issues of CLIA regulation, quality control, and interpretation vaginal wet mount (VWM) for common causes of vaginitis This will be followed by a fifteen minute video that details through the microscope footage of findings on VWM including trichomads, yeast and clue cells associated with BV. The remaining two and one-half hours consists of experiential training, including laboratory practicum on examination of saline and KOH vaginal wet mounts (VWM). During this portion of the training, participants will have an opportunity for group discussion, explanation, and demonstration, as well as practice and return demonstration.
Learning Objectives
Practice proper preparation of saline and KOH specimens of vaginal fluid to increase viability of specimens for microscopic evaluation.
Perform proper use of the light microscope to improve examination of saline and KOH wet mount specimens.
Assess wet mount microscopy specimens to appropriately interpret findings that support diagnosis of vulvovaginal candidiasis, bacterial vaginosis or trichomoniaisis.
URL Redirect: STOMP: Study of Tecovirimat for Mpox